Drug Set To Become The New Standard Therapy For Type 2 Diabetes.

A new drug was so successful in its first trial that it is now being considered the new standard therapy for type 2 .

The drug that is called , is manufactured by Novo Nordisk.

The drug it was discovered was able to significantly reduce levels and body in about 1,200 patients suffering with type 2 diabetes, when compared with dulaglutide.

“We are excited about the potential of semaglutide to set a new standard for of type 2 diabetes,” Novo Nordisk said.
“While we project that Lilly will retain its leadership position in the once-weekly segment, Novo has made headway with its oral formulation that could potentially shift the market dynamics in its favor over the longer term,” Barclays analysts said. source

About Felix Brambaifa 224 Articles
Felix Brambaifa is a writer and blogger from Nigeria. The founder of Naturally Healthy People and other niche blogs.

Be the first to comment

Leave a Reply

Your email address will not be published.


*